MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14756366.2021.2001805

Медицинская библиотека · Journal of enzyme inhibition and medicinal chemistry · 2022

Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition.

Xu Shaohua, Fan Ruolan, Wang Lu, He Weishen, Ge Haixia, Chen Hailan, Xu Wen, Zhang Jian, Xu Wei, Feng Yaqian, Fan Zhimin

СтатьяПеревод в очереди

Аннотация

Using STAT3 inhibitors as a potential strategy in cancer therapy have attracted much attention. Recently, celastrol has been reported that it could directly bind to and suppress the activity of STAT3 in the cardiac dysfunction model. To explore more effective STAT3 inhibiting anti-tumour drug candidates, we synthesised a series of celastrol derivatives and biologically evaluated them with several human cancer cell lines. The western blotting analysis showed that compound 4 m, the most active derivative, could suppress the STAT3's phosphorylation as well as its downstream genes. SPR analysis, molecular docking and dynamics simulations' results indicated that the 4m could bind with STAT3 protein more tightly than celastrol. Then we found that the 4m could block cell-cycle and induce apoptosis on HCT-116 cells. Furthermore, the anti-tumour effect of 4m was verified on colorectal cancer organoid. This is the first research that discovered effective STAT3 inhibitors as potent anti-tumour agents from celastrol derivatives.

Для цитирования: Xu Shaohua, Fan Ruolan, Wang Lu, He Weishen, Ge Haixia, Chen Hailan, Xu Wen, Zhang Jian, Xu Wei, Feng Yaqian, Fan Zhimin. Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibition.. Journal of enzyme inhibition and medicinal chemistry. 2022. DOI: 10.1080/14756366.2021.2001805.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.